{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:59:09Z","timestamp":1791273549898,"version":"4.1.0"},"reference-count":384,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1539,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1439-0507.2011.02040.x","type":"journal-article","created":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T12:48:19Z","timestamp":1308142099000},"page":"279-310","source":"Crossref","is-referenced-by-count":112,"title":["Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy"],"prefix":"10.1111","volume":"54","author":[{"given":"Markus","family":"Ruhnke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Rickerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Buchheidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gl\u00f6ckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"H\u00f6hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Horr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinolf","family":"Karthaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kujath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Willinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Presterl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Glasmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,15]]},"reference":[{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/319366","article-title":"Guide to development of practice guidelines","volume":"32","author":"Kish","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/138945006776359421","article-title":"Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts","volume":"7","author":"Ruhnke","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1089\/088922299309658","article-title":"Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy","volume":"15","author":"Powderly","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1128\/JCM.37.12.3896-3900.1999","article-title":"Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer","volume":"37","author":"Redding","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB6|cit6","first-page":"194","article-title":"Occurrence of oral Candida in irradiated head and neck cancer patients","volume":"39","author":"Silverman","year":"1984","journal-title":"J Oral Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0891-5520(05)70303-2","article-title":"Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients","volume":"10","author":"Walsh","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1601-0825.2006.01357.x","article-title":"Antimicrobials as a contributory factor in oral candidosis - a brief overview","volume":"14","author":"Soysa","year":"2008","journal-title":"Oral Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.oraloncology.2005.11.010","article-title":"Oral candidosis in patients with advanced cancer","volume":"42","author":"Davies","year":"2006","journal-title":"Oral Oncol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.28.12.2733-2738.1990","article-title":"Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe","volume":"28","author":"Reagan","year":"1990","journal-title":"J Clin Microbiol"},{"issue":"Suppl. A","key":"10.1111\/j.1439-0507.2011.02040.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0195-6701(88)90220-4","article-title":"The emergence of fungi as major hospital pathogens","volume":"11","author":"Bodey","year":"1988","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1128\/JCM.32.9.2299-2300.1994","article-title":"High frequency of yeast carriage on hands of hospital personnel","volume":"32","author":"Strausbaugh","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1086\/323759","article-title":"Revisiting the source of candidemia: skin or gut?","volume":"33","author":"Nucci","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/jcp.2009.070607","article-title":"Postmortem candidaemia: marker of disseminated disease","volume":"63","author":"Thorn","year":"2010","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1439-0507.2005.01101.x","article-title":"Candidosis and aspergillosis as autopsy findings from 1994 to 2003","volume":"48","author":"Schwesinger","year":"2005","journal-title":"Mycoses"},{"issue":"Suppl. 1","key":"10.1111\/j.1439-0507.2011.02040.x-BIB16|cit16","first-page":"25","article-title":"Autopsy results of deep mycoses in hematologic neoplasms 1053 patients","volume":"34","author":"Donhuijsen","year":"1991","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.inf.0000128781.77600.6f","article-title":"Risk factors for disseminated candidiasis in children with candidemia","volume":"23","author":"Zaoutis","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/infdis\/135.2.224","article-title":"Role of Candida albicans in granulomatous tissue reactions. I. In vitro degradation of C. albicans and immunospecificity of split products","volume":"135","author":"Meister","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.7326\/0003-4819-108-1-88","article-title":"Hepatic candidiasis in cancer patients: the evolving picture of the syndrome","volume":"108","author":"Thaler","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.leukres.2004.10.003","article-title":"Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment","volume":"29","author":"Masood","year":"2005","journal-title":"Leuk Res"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1378\/chest.124.6.2244","article-title":"Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients","volume":"124","author":"Michalopoulos","year":"2003","journal-title":"Chest"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-8579(00)00147-3","article-title":"Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit","volume":"15","author":"Munoz","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/clinids\/20.6.1531","article-title":"Nosocomial candidemia: risk factors and attributable mortality","volume":"20","author":"Wenzel","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.149.10.2349","article-title":"Risk factors for hospital-acquired candidemia. A matched case-control study","volume":"149","author":"Wey","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00006454-200004000-00011","article-title":"Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group","volume":"19","author":"Saiman","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2007-970078","article-title":"Fungal colonization in the neonatal intensive care unit: risk factors, drug susceptibility, and association with invasive fungal infections","volume":"24","author":"Farmaki","year":"2007","journal-title":"Am J Perinatol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB29|cit29","first-page":"20","article-title":"Systemic candidiasis in cancer patients","volume":"77","author":"Maksymiuk","year":"1984","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(81)90162-5","article-title":"Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality","volume":"71","author":"Meunier-Carpentier","year":"1981","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0002-9343(96)80072-6","article-title":"Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study","volume":"101","author":"Anaissie","year":"1996","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/clinids\/23.5.964","article-title":"Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature","volume":"23","author":"Anaissie","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB33|cit33","first-page":"465","article-title":"Systemic Candida infection in pediatric BM autotransplantation: clinical signs, outcome and prognosis","volume":"11","author":"Besnard","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0959-8049(99)00052-0","article-title":"Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section","volume":"35","author":"Viscoli","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/clind\/15.3.414","article-title":"Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality","volume":"15","author":"Fraser","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/164.4.731","article-title":"Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation","volume":"164","author":"Goodrich","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1054-139X(01)00280-4","article-title":"HIV-related oral manifestations among adolescents in a multicenter cohort study","volume":"29","author":"Shiboski","year":"2001","journal-title":"J Adolesc Health"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB44|cit44","first-page":"447","article-title":"Reduction in oropharyngeal candidiasis following introduction of protease inhibitors","volume":"12","author":"Hood","year":"1998","journal-title":"AIDS"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00006454-200205000-00008","article-title":"Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy","volume":"21","author":"Chiou","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jac\/40.6.855","article-title":"Fluconazole versus nystatin in the prevention of Candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer","volume":"40","author":"Groll","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/516315","article-title":"Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues","volume":"26","author":"Darouiche","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"Pt 7","key":"10.1111\/j.1439-0507.2011.02040.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1099\/13500872-141-7-1507","article-title":"Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals","volume":"141","author":"Sullivan","year":"1995","journal-title":"Microbiology"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/423377","article-title":"A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients","volume":"39","author":"de Wet","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.diagmicrobio.2005.03.002","article-title":"Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children\u2019s hospitals","volume":"52","author":"Zaoutis","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.40.4.1298-1302.2002","article-title":"Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study","volume":"40","author":"Diekema","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/342300","article-title":"Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999","volume":"35","author":"Trick","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/313450","article-title":"The epidemiology of candidemia in two United States cities: results of a population-based active surveillance","volume":"29","author":"Kao","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/513196","article-title":"Outcomes attributable to neonatal candidiasis","volume":"44","author":"Zaoutis","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.274.8.639","article-title":"The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care EPIC) Study. EPIC International Advisory Committee","volume":"274","author":"Vincent","year":"1995","journal-title":"JAMA"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-4453(96)92700-0","article-title":"Trends in the postmortem epidemiology of invasive fungal infections at a university hospital","volume":"33","author":"Groll","year":"1996","journal-title":"J Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF01964058","article-title":"Candidiasis","volume":"8","author":"Meunier","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/pbc.10452","article-title":"Candida infections in children treated with conventional chemotherapy for solid tumors (transplant recipients excluded): The Institut Gustave Roussy Pediatrics Department experience","volume":"42","author":"Ridola","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl. 3","key":"10.1111\/j.1439-0507.2011.02040.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1093\/clinids\/12.Supplement_3.S369","article-title":"Prophylaxis of oropharyngeal candidiasis with fluconazole","volume":"12","author":"Samonis","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/517849","article-title":"Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality - SEIFEM-C Report","volume":"44","author":"Pagano","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB66|cit66","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-0691.2008.01954.x","article-title":"Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility","volume":"14","author":"Arendrup","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/00365540310017447","article-title":"A prospective epidemiological survey of candidaemia in Sweden","volume":"36","author":"Klingspor","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3201\/eid0908.030069","article-title":"Candidemia in Finland, 1995-1999","volume":"9","author":"Poikonen","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/JCM.00029-06","article-title":"Candidemia in Norway (1991 to 2003): results from a nationwide study","volume":"44","author":"Sandven","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0732-8893(99)00096-6","article-title":"Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group","volume":"36","author":"Krcmery","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-6-80","article-title":"Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links","volume":"6","author":"Sendid","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/JCM.44.5.1681-1685.2006","article-title":"Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003","volume":"44","author":"Almirante","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.diagmicrobio.2007.01.005","article-title":"Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals","volume":"58","author":"Bassetti","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/JCM.43.9.4434-4440.2005","article-title":"Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility","volume":"43","author":"Arendrup","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0195-6701(03)00085-9","article-title":"Management and outcome of bloodstream infections due to Candida species in England and Wales","volume":"54","author":"Kibbler","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jac\/dkm145","article-title":"Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005","volume":"60","author":"Borg-von-Zepelin","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/AAC.01217-06","article-title":"In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates","volume":"51","author":"Seifert","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/clinids\/12.3.406","article-title":"Invasive infection with Saccharomyces cerevisiae: report of three cases and review","volume":"12","author":"Aucott","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/jac\/41.3.373","article-title":"Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome","volume":"41","author":"Krcmery","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s005200050304","article-title":"Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10\u2003years in a single cancer institution","volume":"7","author":"Krcmery","year":"1999","journal-title":"Support Care Cancer"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0195-6701(99)90015-4","article-title":"Invasive yeast infections other than Candida spp. in acute leukaemia","volume":"41","author":"Krcmery","year":"1999","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhin.2001.1151","article-title":"Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance","volume":"50","author":"Krcmery","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1086\/518175","article-title":"Mixed fungemia: incidence, risk factors, and mortality in a general hospital","volume":"44","author":"Jensen","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.43.4.1818-1828.2005","article-title":"Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature","volume":"43","author":"Girmenia","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"Suppl. 2","key":"10.1111\/j.1439-0507.2011.02040.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1469-0691.2001.tb00005.x","article-title":"Uncommon opportunistic fungi: new nosocomial threats","volume":"7","author":"Groll","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/BF02447924","article-title":"Mixed Candida glabrata and Candida albicans disseminated candidiasis in a heroin addict","volume":"16","author":"Bougnoux","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB89|cit89","first-page":"407","volume-title":"Candidiasis","author":"Bodey","year":"1993"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1610-0387.2008.06801.x","article-title":"Oral candidiasis","volume":"6","author":"Reinel","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/00002030-199111000-00009","article-title":"Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS","volume":"5","author":"Dodd","year":"1991","journal-title":"AIDS"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(96)02308-2","article-title":"HIV-related oral disease","volume":"348","author":"Greenspan","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/myc.1990.33.9-10.421","article-title":"Oral candidosis in HIV-infected patients. Prognostic value and correlation with immunological parameters","volume":"33","author":"Plettenberg","year":"1990","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1067\/moe.2000.108799","article-title":"Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV\/AIDS as markers of immune suppression and viral burden","volume":"90","author":"Patton","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"Suppl. 2","key":"10.1111\/j.1439-0507.2011.02040.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1034\/j.1601-0825.2002.00020.x","article-title":"Prevalence and classification of HIV-associated oral lesions","volume":"8","author":"Patton","year":"2002","journal-title":"Oral Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1054-3589(08)60955-2","article-title":"Update on invasive candidiasis","volume":"37","author":"Rodriguez","year":"1997","journal-title":"Adv Pharmacol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB97|cit97","first-page":"187","article-title":"Invasive fungal infections in children: recent advances in diagnosis and treatment","volume":"11","author":"Walsh","year":"1996","journal-title":"Adv Pediatr Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.0933-7407.2003.00909.x","article-title":"Guideline vulvovaginal candidosis: guideline of the German Dermatological Society, the German Speaking Mycological Society and the Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics","volume":"46","author":"Mendling","year":"2003","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1610-0387.2007.06134.x","article-title":"Onychomycosis","volume":"5","author":"Seebacher","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1469-0691.2005.01318.x","article-title":"Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp","volume":"12","author":"Wisplinghoff","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0891-5520(02)00034-X","article-title":"Deeply invasive candidiasis","volume":"16","author":"Ostrosky-Zeichner","year":"2002","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB102|cit102","first-page":"535","article-title":"Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes","volume":"87","author":"Pagano","year":"2002","journal-title":"Haematologica"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1055\/s-2006-956541","article-title":"Imaging in hepatosplenic candidiasis","volume":"178","author":"Horger","year":"2006","journal-title":"Rofo"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1182\/blood.V91.8.3087.3087_3087_3089","article-title":"Hepatic lesions of chronic disseminated systemic candidiasis in leukemia patients may become visible during neutropenia: value of serial ultrasound examinations","volume":"91","author":"Karthaus","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood.V90.10.3858","article-title":"Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia","volume":"90","author":"Pestalozzi","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"dePauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann Surg"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1016\/S0002-9610(96)00350-9","article-title":"Timing of treatment for nonneutropenic patients colonized with Candida","volume":"172","author":"Solomkin","year":"1996","journal-title":"Am J Surg"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S1473-3099(03)00831-4","article-title":"Management of Candida species infections in critically ill patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00134-009-1619-9","article-title":"Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients","volume":"35","author":"Playford","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","article-title":"Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients","volume":"32","author":"Piarroux","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Leon","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting","volume":"26","author":"Ostrosky-Zeichner","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \u201cCandida score\u201d for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study","volume":"37","author":"Leon","year":"2009","journal-title":"Crit Care Med"},{"issue":"Suppl. 2","key":"10.1111\/j.1439-0507.2011.02040.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1007\/s00277-003-0768-0","article-title":"Diagnosis of invasive fungal infections in hematology and oncology - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"82","author":"Ruhnke","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1128\/JCM.01555-07","article-title":"Detection of bloodstream infections in adults: how many blood cultures are needed?","volume":"45","author":"Lee","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1128\/JCM.00966-07","article-title":"Detection of fifteen species of Candida in an automated blood culture system","volume":"45","author":"Horvath","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/JCM.42.1.115-118.2004","article-title":"Direct comparison of the BACTEC 9240 and BacT\/ALERT 3D automated blood culture systems for Candida growth detection","volume":"42","author":"Horvath","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/JCM.42.4.1855-1856.2004","article-title":"Use of the BACTEC 9240 System with Mycosis-IC\/F blood culture bottles for detection of fungemia","volume":"42","author":"Fricker-Hidalgo","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/JCM.32.4.975-980.1994","article-title":"Investigation of the sequence of colonization and candidemia in nonneutropenic patients","volume":"32","author":"Voss","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/382874","article-title":"Management of central venous catheters in patients with cancer and candidemia","volume":"38","author":"Raad","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/qjmed\/hcl087","article-title":"Candidaemia in a large teaching hospital: a clinical audit","volume":"99","author":"Aliyu","year":"2006","journal-title":"QJM"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1128\/JCM.00214-08","article-title":"Time to blood culture positivity as a marker for catheter-related candidemia","volume":"46","author":"Ben-Ami","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-140-1-200401060-00007","article-title":"Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections","volume":"140","author":"Raad","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/AAC.00945-09","article-title":"Effect of antifungal therapy timing on mortality in cancer patients with candidemia","volume":"54","author":"Taur","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0732-8893(93)90020-8","article-title":"Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection","volume":"17","author":"Berenguer","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl. 6","key":"10.1111\/j.1439-0507.2011.02040.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.1086\/430918","article-title":"Candiduria","volume":"41","author":"Kauffman","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1007\/s00134-009-1482-8","article-title":"Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study","volume":"35","author":"Meersseman","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1469-0691.2003.00592.x","article-title":"Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)","volume":"9","author":"Cuenca-Estrella","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1128\/JCM.43.8.3884-3889.2005","article-title":"International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole","volume":"43","author":"Espinel-Ingroff","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1128\/JCM.43.10.5243-5246.2005","article-title":"Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole","volume":"43","author":"Espinel-Ingroff","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1086\/344058","article-title":"Antifungal resistance in pathogenic fungi","volume":"35","author":"Perea","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/342384","article-title":"Has antifungal susceptibility testing come of age?","volume":"35","author":"Rex","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","article-title":"Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB135|cit135","first-page":"1","article-title":"Reference Method for Broth Dilution Antifungal Susceptibility testing of Yeasts. Approved Standard M27-A3","volume":"28","author":"Clinical and Laboratory Standards Institute","year":"2008","journal-title":"Clinical and Laboratory Standards Institute"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB136|cit136","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1469-0691.2008.02087.x","article-title":"EUCAST technical note on voriconazole","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee on Antimicrobial Susceptibility Testing (EUCAST)","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1469-0691.2007.01899.x","article-title":"EUCAST technical note on fluconazole","volume":"14","author":"The European Committee on Antimicrobial Susceptibility Testing - Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST)","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.39.1.40","article-title":"Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group","volume":"39","author":"Rex","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB139|cit139","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/CMR.14.4.643-658.2001","article-title":"Antifungal susceptibility testing: practical aspects and current challenges","volume":"14","author":"Rex","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/CMR.19.2.435-447.2006","article-title":"Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing","volume":"19","author":"Pfaller","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/AAC.00474-06","article-title":"Association of fluconazole area under the concentration-time curve\/MIC and dose\/MIC ratios with mortality in nonneutropenic patients with candidemia","volume":"51","author":"Pai","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB142|cit142","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/JCM.01969-06","article-title":"Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)","volume":"45","author":"Rodriguez-Tudela","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB143|cit143","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/JCM.01385-07","article-title":"Multicenter evaluation of the Candida albicans\/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles","volume":"46","author":"Shepard","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1128\/JCM.00389-09","article-title":"Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates","volume":"47","author":"Marklein","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"Suppl. 1","key":"10.1111\/j.1439-0507.2011.02040.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/mmy.38.s1.147.159","article-title":"Non-culture based diagnostic tests for mycotic infections","volume":"38","author":"Reiss","year":"2000","journal-title":"Med Mycol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB146|cit146","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/JCM.34.8.1918-1921.1996","article-title":"Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia","volume":"34","author":"Mitsutake","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB147|cit147","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s100960100629","article-title":"Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis","volume":"20","author":"Yera","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB148|cit148","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1099\/0022-1317-51-5-433","article-title":"Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species","volume":"51","author":"Sendid","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB149|cit149","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1128\/JCM.41.10.4551-4558.2003","article-title":"Contribution of the platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults","volume":"41","author":"Sendid","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB150|cit150","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1128\/JCM.43.5.2181-2187.2005","article-title":"Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections","volume":"43","author":"White","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB151|cit151","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1439-0507.2001.00616.x","article-title":"The utility of serology in diagnosing candidosis in non-neutropenic critically ill patients","volume":"44","author":"Ibanez-Nolla","year":"2001","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB152|cit152","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/JCM.30.8.2158-2164.1992","article-title":"Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis","volume":"30","author":"Herent","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB153|cit153","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.diagmicrobio.2004.08.015","article-title":"Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies","volume":"51","author":"Prella","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB154|cit154","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","article-title":"Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"39","author":"Odabasi","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB155|cit155","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u21923) beta-d-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB156|cit156","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijid.2008.10.013","article-title":"Invasive fungal infections and (1,3)-beta-d-glucan serum concentrations in long-term intensive care patients","volume":"13","author":"Presterl","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB157|cit157","first-page":"338","article-title":"Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene","volume":"108","author":"Buchman","year":"1990","journal-title":"Surgery"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB158|cit158","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1128\/JCM.35.6.1353-1360.1997","article-title":"Detection and identification of fungal pathogens in blood by using molecular probes","volume":"35","author":"Einsele","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB159|cit159","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/00365549409008623","article-title":"Detection of Candida albicans DNA in serum by polymerase chain reaction","volume":"26","author":"Chryssanthou","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB160|cit160","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/JCM.33.4.962-967.1995","article-title":"Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood","volume":"33","author":"Fujita","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB161|cit161","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1567-1364.2006.00108.x","article-title":"Use of DNA microarray technology and gene expression profiles to investigate the pathogenesis, cell biology, antifungal susceptibility and diagnosis of Candida albicans","volume":"6","author":"Garaizar","year":"2006","journal-title":"FEMS Yeast Res"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB162|cit162","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/JCM.44.1.143-150.2006","article-title":"Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive Candidiasis","volume":"44","author":"Kasai","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB163|cit163","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1469-0691.2006.01498.x","article-title":"Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR","volume":"12","author":"Klingspor","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB164|cit164","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2180-7-78","article-title":"Identification of human pathogens isolated from blood using microarray hybridisation and signal pattern recognition","volume":"7","author":"Wiesinger-Mayr","year":"2007","journal-title":"BMC Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB165|cit165","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/13693780701501787","article-title":"Multiplex PCR identification of eight clinically relevant Candida species","volume":"45","author":"Carvalho","year":"2007","journal-title":"Med Mycol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB166|cit166","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/JCM.00942-07","article-title":"DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients","volume":"45","author":"Spiess","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB167|cit167","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1099\/jmm.0.47617-0","article-title":"Improving molecular detection of Candida DNA in whole blood: comparison of seven fungal DNA extraction protocols using real-time PCR","volume":"57","author":"Metwally","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB168|cit168","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/JCM.01344-06","article-title":"Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens","volume":"45","author":"Schabereiter-Gurtner","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB169|cit169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2009.01575.x","article-title":"An update on the molecular diagnosis of invasive fungal disease","volume":"296","author":"White","year":"2009","journal-title":"FEMS Microbiol Lett"},{"issue":"Suppl. 2","key":"10.1111\/j.1439-0507.2011.02040.x-BIB170|cit170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/1120009X.2007.11782441","article-title":"New diagnostic tools for neonatal sepsis: the role of a real-time polymerase chain reaction for the early detection and identification of bacterial and fungal species in blood samples","volume":"19","author":"Mussap","year":"2007","journal-title":"J Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB171|cit171","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/clinids\/20.4.801","article-title":"Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors, and clinical features","volume":"20","author":"Rossetti","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB172|cit172","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1099\/00222615-47-9-811","article-title":"Molecular probes for the detection of pathogenic fungi in the presence of human tissue","volume":"47","author":"Kappe","year":"1998","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB173|cit173","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF01708552","article-title":"Diagnostic laparoscopy in patients with acute leukemia and suspected hepatic candidiasis","volume":"16","author":"Anttila","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB174|cit174","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jmri.1880020315","article-title":"Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging","volume":"2","author":"Semelka","year":"1992","journal-title":"J Magn Reson Imaging"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB175|cit175","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2214\/ajr.169.5.9353448","article-title":"Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging","volume":"169","author":"Semelka","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB176|cit176","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1148\/radiology.166.2.3275982","article-title":"Hepatosplenic candidiasis: wheels within wheels","volume":"166","author":"Pastakia","year":"1988","journal-title":"Radiology"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB177|cit177","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0609.1996.tb00300.x","article-title":"Magnetic resonance imaging is superior to computed tomography and ultrasonography in imaging infectious liver foci in acute leukaemia","volume":"56","author":"Anttila","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB178|cit178","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/02841850410006191","article-title":"Unusual enhancement pattern of liver lesions in hepatosplenic candidiasis","volume":"45","author":"Rudolph","year":"2004","journal-title":"Acta Radiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB179|cit179","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/jac\/33.3.603","article-title":"A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies","volume":"33","author":"Caillot","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB180|cit180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/bmj.317.7155.379","article-title":"Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study","volume":"317","author":"Schoffski","year":"1998","journal-title":"BMJ"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB181|cit181","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jac\/35.2.241","article-title":"Flucytosine - what is its future?","volume":"35","author":"Viviani","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB182|cit182","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/clind\/15.6.1003","article-title":"Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy","volume":"15","author":"Francis","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB183|cit183","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/jac\/dkl550","article-title":"Flucytosine therapeutic monitoring: 15\u2003years experience from the UK","volume":"59","author":"Pasqualotto","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 7","key":"10.1111\/j.1439-0507.2011.02040.x-BIB184|cit184","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1469-0691.2006.01609.x","article-title":"Current experience with itraconazole in neutropenic patients: a concise overview of pharmacological properties and use in prophylactic and empirical antifungal therapy","volume":"12","author":"Glasmacher","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB185|cit185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB186|cit186","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB187|cit187","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2165\/00003495-200464180-00001","article-title":"Newer systemic antifungal agents: pharmacokinetics, safety and efficacy","volume":"64","author":"Boucher","year":"2004","journal-title":"Drugs"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB188|cit188","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0891-5520(02)00068-5","article-title":"Clinical pharsmacology of antifungal compounds","volume":"17","author":"Groll","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB189|cit189","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.47.10.3149-3154.2003","article-title":"Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States","volume":"47","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB190|cit190","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/JCM.43.11.5425-5427.2005","article-title":"In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB191|cit191","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB192|cit192","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB193|cit193","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB194|cit194","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB195|cit195","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB196|cit196","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB197|cit197","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1086\/598933","article-title":"A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis","volume":"48","author":"Betts","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB198|cit198","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/JCM.44.3.760-763.2006","article-title":"In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB199|cit199","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s15010-006-5613-7","article-title":"Development of candidemia on caspofungin therapy: a case report","volume":"34","author":"Cheung","year":"2006","journal-title":"Infection"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB200|cit200","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB201|cit201","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB202|cit202","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1517\/14656566.6.7.1215","article-title":"Voriconazole: review of a broad spectrum triazole antifungal agent","volume":"6","author":"Kofla","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB203|cit203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-3-642-84138-5_41","article-title":"Influence of infusion time on the acute toxicity of amphotericin B: results of a randomized double-blind study","volume":"121","author":"Arning","year":"1991","journal-title":"Recent Results Cancer Res"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB204|cit204","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1046\/j.1523-1755.2001.00948.x","article-title":"Correlates of acute renal failure in patients receiving parenteral amphotericin B","volume":"60","author":"Bates","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB205|cit205","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/319211","article-title":"Mortality and costs of acute renal failure associated with amphotericin B therapy","volume":"32","author":"Bates","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB206|cit206","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-9343(01)00928-7","article-title":"The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy","volume":"111","author":"Harbarth","year":"2001","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB207|cit207","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/376634","article-title":"Amphotericin B: time for a new \u201cgold standard\u201d","volume":"37","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB208|cit208","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0002-9343(98)00030-8","article-title":"Predictors of adverse outcome in cancer patients with candidemia","volume":"104","author":"Anaissie","year":"1998","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB209|cit209","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00277-008-0622-5","article-title":"Treatment of invasive fungal infections in cancer patients - recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"88","author":"B\u00f6hme","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB210|cit210","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.322.7286.579","article-title":"Comparison of effects of amphotericin B deoxycholate infused over 4 or 24\u2003hours: randomised controlled trial","volume":"322","author":"Eriksson","year":"2001","journal-title":"BMJ"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB211|cit211","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/clinids\/6.6.791","article-title":"Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis","volume":"6","author":"Smego","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB212|cit212","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF01728917","article-title":"Comparative study of the efficacy of fluconazole versus amphotericin B\/flucytosine in surgical patients with systemic mycoses","volume":"21","author":"Kujath","year":"1993","journal-title":"Infection"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB213|cit213","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF01713042","article-title":"A randomized study comparing fluconazole with amphotericin B\/5-flucytosine for the treatment of systemic Candida infections in intensive care patients","volume":"24","author":"Abele-Horn","year":"1996","journal-title":"Infection"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB214|cit214","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB215|cit215","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00134-009-1431-6","article-title":"Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?","volume":"35","author":"Perez-Parra","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB216|cit216","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1097\/CCM.0b013e31818b3477","article-title":"Treatment-related risk factors for hospital mortality in Candida bloodstream infections","volume":"36","author":"Labelle","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB217|cit217","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB218|cit218","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jac\/dki491","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials","volume":"57","author":"Playford","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB219|cit219","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","article-title":"Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients","volume":"233","author":"Pelz","year":"2001","journal-title":"Ann Surg"},{"issue":"Suppl. 6","key":"10.1111\/j.1439-0507.2011.02040.x-BIB220|cit220","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1086\/429330","article-title":"Treatment of Candida infections with amphotericin B lipid complex","volume":"40","author":"Ito","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB221|cit221","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2006.05.002","article-title":"EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours","volume":"42","author":"Aapro","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB222|cit222","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/BF01690878","article-title":"Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis","volume":"14","author":"Graybill","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB223|cit223","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/cncr.20710","article-title":"Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections","volume":"101","author":"Safdar","year":"2004","journal-title":"Cancer"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB224|cit224","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB225|cit225","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/00365540410020703","article-title":"Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD)","volume":"36","author":"Benjamin","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB226|cit226","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0891-5520(01)00008-3","article-title":"Infective endocarditis in intravenous drug abusers and HIV-1 infected patients","volume":"16","author":"Miro","year":"2002","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB227|cit227","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/infdis\/156.5.857","article-title":"Systemic candidiasis in Spanish heroin addicts: a possible source of infection","volume":"156","author":"Miro","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB228|cit228","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/clinids\/21.4.994","article-title":"Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group","volume":"21","author":"Rex","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 6","key":"10.1111\/j.1439-0507.2011.02040.x-BIB229|cit229","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1086\/430923","article-title":"Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies","volume":"41","author":"Wenzel","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB230|cit230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB231|cit231","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1473-3099(07)70235-9","article-title":"Intravascular catheter-related infections: advances in diagnosis, prevention, and management","volume":"7","author":"Raad","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB232|cit232","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00277-008-0509-5","article-title":"Central venous catheter-related infections in hematology and oncology : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"87","author":"Wolf","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB233|cit233","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1128\/AAC.47.11.3657-3659.2003","article-title":"Antifungal combinations against Candida albicans biofilms in vitro","volume":"47","author":"Bachmann","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB234|cit234","first-page":"42","article-title":"Biofilms of Candida albicans and their associated resistance to antifungal agents","volume":"20","author":"Ramage","year":"2001","journal-title":"Am Clin Lab"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB235|cit235","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/AAC.48.5.1727-1732.2004","article-title":"Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy","volume":"48","author":"Schinabeck","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1111\/j.1439-0507.2011.02040.x-BIB236|cit236","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1055\/s-2005-872501","article-title":"Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients","volume":"217","author":"Groll","year":"2005","journal-title":"Klin Padiatr"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB237|cit237","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1517\/14656566.8.15.2465","article-title":"Clinical pharmacology of antifungal agents in pediatric patients","volume":"8","author":"Chiou","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB238|cit238","first-page":"303","article-title":"Antifungal chemotherapy: advances and perspectives","volume":"132","author":"Groll","year":"2002","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB239|cit239","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/AAC.49.11.4536-4545.2005","article-title":"Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents","volume":"49","author":"Walsh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB240|cit240","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.inf.0000145408.51526.0a","article-title":"Caspofungin therapy of neonates with invasive candidiasis","volume":"23","author":"Odio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB241|cit241","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-3476(05)81975-4","article-title":"Safety and pharmacokinetics of fluconazole in children with neoplastic diseases","volume":"120","author":"Lee","year":"1992","journal-title":"J Pediatr"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB242|cit242","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.49.8.3317-3324.2005","article-title":"Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients","volume":"49","author":"Seibel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB243|cit243","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.inf.0000153183.51258.b8","article-title":"Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections","volume":"24","author":"Wiley","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB244|cit244","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","article-title":"Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial","volume":"27","author":"Queiroz-Telles","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB245|cit245","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/AAC.43.8.1955","article-title":"Safety and tolerability of fluconazole in children","volume":"43","author":"Novelli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB246|cit246","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1542\/peds.2008-1158","article-title":"A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients","volume":"123","author":"Zaoutis","year":"2009","journal-title":"Pediatrics"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB247|cit247","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/AAC.48.6.2166-2172.2004","article-title":"Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration","volume":"48","author":"Walsh","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB248|cit248","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00006454-199908000-00010","article-title":"Amphotericin B lipid complex in pediatric patients with invasive fungal infections","volume":"18","author":"Walsh","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB249|cit249","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/00006454-199710000-00020","article-title":"Lack of evidence of amphotericin B toxicity in very low birth weight infants treated for systemic candidiasis","volume":"16","author":"Kingo","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB250|cit250","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10096-003-0993-4","article-title":"High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates","volume":"22","author":"Juster-Reicher","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB251|cit251","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s150100070040","article-title":"Liposomal amphotericin B (AmBisome) in the treatment of neonatal candidiasis in very low birth weight infants","volume":"28","author":"Juster-Reicher","year":"2000","journal-title":"Infection"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB252|cit252","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1128\/AAC.49.12.5092-5098.2005","article-title":"Population pharmacokinetics of amphotericin B lipid complex in neonates","volume":"49","author":"W\u00fcrthwein","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB253|cit253","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/01.inf.0000245103.07614.e1","article-title":"The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants","volume":"25","author":"Heresi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB254|cit254","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jac\/dkm169","article-title":"Caspofungin for the treatment of less common forms of invasive candidiasis","volume":"60","author":"Cornely","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB255|cit255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01639520","article-title":"Combination therapy for systemic mycosis","volume":"17","author":"Polak","year":"1989","journal-title":"Infection"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB256|cit256","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis","volume":"301","author":"Bennett","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB257|cit257","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00023210-200721040-00004","article-title":"Fungal infections of the CNS: treatment strategies for the immunocompromised patient","volume":"21","author":"Black","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB258|cit258","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system","volume":"182","author":"Groll","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB259|cit259","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jac\/dki473","article-title":"Fluconazole for the management of invasive candidiasis: where do we stand after 15\u2003years?","volume":"57","author":"Charlier","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB260|cit260","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/377131","article-title":"Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients","volume":"37","author":"Lutsar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB261|cit261","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB262|cit262","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1439-0507.2007.01345.x","article-title":"Poor efficacy of amphotericin B-based therapy in CNS aspergillosis","volume":"50","author":"Schwartz","year":"2007","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB263|cit263","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1128\/AAC.43.9.2148","article-title":"Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits","volume":"43","author":"Petraitiene","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB264|cit264","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1128\/AAC.46.6.1857-1869.2002","article-title":"Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits","volume":"46","author":"Petraitis","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB265|cit265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1086\/524063","article-title":"The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous candida meningoencephalitis: implications for echinocandin therapy in neonates","volume":"197","author":"Hope","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB266|cit266","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1128\/JCM.42.12.5950-5953.2004","article-title":"Refractory candidal meningitis in an immunocompromised patient cured by caspofungin","volume":"42","author":"Liu","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB267|cit267","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1592\/phco.27.12.1711","article-title":"Candida endophthalmitis: focus on current and future antifungal treatment options","volume":"27","author":"Khan","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB268|cit268","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.md.0000076008.64510.f1","article-title":"Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology","volume":"82","author":"Rodriguez-Adrian","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB269|cit269","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0161-6420(94)31175-4","article-title":"Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study","volume":"101","author":"Donahue","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB270|cit270","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1542\/peds.112.3.634","article-title":"Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques","volume":"112","author":"Benjamin","year":"2003","journal-title":"Pediatrics"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB271|cit271","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/bmj.287.6396.861","article-title":"Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers","volume":"287","author":"Collignon","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"Suppl. A","key":"10.1111\/j.1439-0507.2011.02040.x-BIB272|cit272","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/28.suppl_A.83","article-title":"Fungal infections in drug users","volume":"28","author":"Leen","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB273|cit273","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1086\/427753","article-title":"Candida glabrata endophthalmitis treated successfully with caspofungin","volume":"40","author":"Sarria","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB274|cit274","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1086\/431761","article-title":"Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis","volume":"41","author":"Gauthier","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB275|cit275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajo.2004.08.077","article-title":"Management of endogenous fungal endophthalmitis with voriconazole and caspofungin","volume":"139","author":"Breit","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB276|cit276","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3928\/1542-8877-19970301-03","article-title":"Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis","volume":"28","author":"Essman","year":"1997","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB277|cit277","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1086\/514972","article-title":"Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy","volume":"27","author":"Martinez-Vazquez","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB278|cit278","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/ICO.0b013e31802cd8a8","article-title":"Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits","volume":"26","author":"Hiraoka","year":"2007","journal-title":"Cornea"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB279|cit279","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.ico.0000154390.28254.54","article-title":"Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: report of three cases and literature review","volume":"24","author":"Matsumoto","year":"2005","journal-title":"Cornea"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB280|cit280","first-page":"391","article-title":"Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis","volume":"4","author":"Al-Badriyeh","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB281|cit281","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMra010082","article-title":"Infective endocarditis in adults","volume":"345","author":"Mylonakis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB282|cit282","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1378\/chest.122.1.302","article-title":"Fungal endocarditis, 1995-2000","volume":"122","author":"Pierrotti","year":"2002","journal-title":"Chest"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB283|cit283","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1378\/chest.06-2048","article-title":"A systematic review of population-based studies of infective endocarditis","volume":"132","author":"Tleyjeh","year":"2007","journal-title":"Chest"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB284|cit284","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jinf.2004.10.016","article-title":"A meta-analysis of medical versus surgical therapy for Candida endocarditis","volume":"51","author":"Steinbach","year":"2005","journal-title":"J Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB285|cit285","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/00365540601131968","article-title":"Candida albicans tricuspid and pulmonic valve endocarditis: challenge of relapsing risk and role of combined medical treatment and surgery","volume":"39","author":"Salamon","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB286|cit286","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10096-008-0466-x","article-title":"Candida infective endocarditis","volume":"28","author":"Baddley","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB287|cit287","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/317550","article-title":"Fungal endocarditis: evidence in the world literature, 1965-1995","volume":"32","author":"Ellis","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB288|cit288","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9343(97)90050-4","article-title":"Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia","volume":"103","author":"Nasser","year":"1997","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB289|cit289","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/00365540410021207-1","article-title":"Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole","volume":"37","author":"Westling","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB290|cit290","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/00365540050164281","article-title":"Successful non-surgical treatment of Candida tropicalis endocarditis with liposomal amphotericin-B (AmBisome)","volume":"32","author":"Melamed","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB291|cit291","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00431-007-0634-5","article-title":"Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates","volume":"167","author":"Karatza","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB292|cit292","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1086\/424018","article-title":"Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment","volume":"39","author":"Jimenez-Exposito","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB293|cit293","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10096-005-0038-2","article-title":"Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review","volume":"24","author":"Lye","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB294|cit294","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijantimicag.2007.04.007","article-title":"Cure of Candida glabrata native tricuspid valve endocarditis by continuous infusion of conventional amphotericin B in a patient with nephrotic syndrome","volume":"30","author":"Williams","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB295|cit295","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jinf.2005.10.003","article-title":"Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient - case report and review of literature","volume":"53","author":"Bacak","year":"2006","journal-title":"J Infect"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB296|cit296","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2334-6-73","article-title":"Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole","volume":"6","author":"Lopez-Ciudad","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB297|cit297","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.49.2.767-769.2005","article-title":"Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis","volume":"49","author":"Moudgal","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB298|cit298","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.114.1.146","article-title":"The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients","volume":"114","author":"Rello","year":"1998","journal-title":"Chest"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB299|cit299","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00134-004-2316-3","article-title":"Practices in non-neutropenic ICU patients with Candida-positive airway specimens","volume":"30","author":"Azoulay","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB300|cit300","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-2141.2002.03414.x","article-title":"Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy","volume":"117","author":"Kami","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB301|cit301","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1440-1827.2003.01548.x","article-title":"Increase in aspergillosis and severe mycotic infection in patients with leukemia and MDS: comparison of the data from the Annual of the Pathological Autopsy Cases in Japan in 1989, 1993 and 1997","volume":"53","author":"Kume","year":"2003","journal-title":"Pathol Int"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB302|cit302","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0002-9343(77)90546-0","article-title":"Pulmonary disease caused by Candida species","volume":"63","author":"Masur","year":"1977","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB303|cit303","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00005792-199305000-00001","article-title":"Primary Candida pneumonia. Experience at a large cancer center and review of the literature","volume":"72","author":"Haron","year":"1993","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB304|cit304","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1164\/ajrccm.156.2.9612023","article-title":"Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study","volume":"156","author":"el-Ebiary","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB305|cit305","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/338404","article-title":"Pulmonary candidiasis in patients with cancer: an autopsy study","volume":"34","author":"Kontoyiannis","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB306|cit306","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.91.4.482","article-title":"Candida epiglottitis in immunocompromised patients","volume":"91","author":"Walsh","year":"1987","journal-title":"Chest"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB307|cit307","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.mph.0000243654.18314.c1","article-title":"Concomitant Candida epiglottitis and disseminated Varicella zoster virus infection associated with acute lymphoblastic leukemia","volume":"28","author":"Chiou","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB308|cit308","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0272-6386(96)90135-3","article-title":"Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes","volume":"28","author":"Goldie","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB309|cit309","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0002-9343(89)90481-6","article-title":"Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent","volume":"86","author":"Levine","year":"1989","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB310|cit310","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(89)92043-6","article-title":"Clinical significance of Candida isolated from peritoneum in surgical patients","volume":"2","author":"Calandra","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB311|cit311","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","article-title":"Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients","volume":"27","author":"Eggimann","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB312|cit312","first-page":"323","article-title":"Diagnostic factors for postoperative candidosis in abdominal surgery","volume":"80","author":"Rantala","year":"1991","journal-title":"Ann Chir Gynaecol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB313|cit313","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MCC.0b013e328028fd92","article-title":"Candida peritonitis","volume":"13","author":"Blot","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB314|cit314","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00104-008-1484-z","article-title":"Antimicrobial and antimycotic therapy of intra-abdominal infections","volume":"79","author":"Kujath","year":"2008","journal-title":"Chirurg"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB315|cit315","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/01.CCM.0000201889.39443.D2","article-title":"Candida as a risk factor for mortality in peritonitis","volume":"34","author":"Montravers","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB316|cit316","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/ndt\/gfi162","article-title":"Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy","volume":"21","author":"Fourtounas","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB317|cit317","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1345\/aph.1M350","article-title":"Neonatal peritoneal candidiasis successfully treated with anidulafungin add-on therapy","volume":"43","author":"Varisco","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB318|cit318","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.idc.2005.08.004","article-title":"Fungal arthritis and osteomyelitis","volume":"19","author":"Kohli","year":"2005","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB319|cit319","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1345\/aph.1M143","article-title":"Delivery of antifungal agents using bioactive and nonbioactive bone cements","volume":"43","author":"Sealy","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB320|cit320","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/00365540500447192","article-title":"Successful treatment of Candida parapsilosis (fluconazole-resistant) osteomyelitis with caspofungin in a HIV patient","volume":"38","author":"Legout","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB321|cit321","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s00586-005-0038-z","article-title":"Candida albicans osteomyelitis of the spine: progressive clinical and radiological features and surgical management in three cases","volume":"15","author":"Khazim","year":"2006","journal-title":"Eur Spine J"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB322|cit322","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/13693780701552996","article-title":"Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin\/posaconazole therapy","volume":"46","author":"Schilling","year":"2008","journal-title":"Med Mycol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB323|cit323","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/08035250500491629","article-title":"Successful treatment of Candida tropicalis arthritis, osteomyelitis and costochondritis with caspofungin and fluconazole in a recipient of bone marrow transplantation","volume":"95","author":"Yang","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB324|cit324","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1086\/521253","article-title":"Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole","volume":"45","author":"Sili","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB325|cit325","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/428734","article-title":"Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases","volume":"40","author":"Mouas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB326|cit326","first-page":"1422","article-title":"Long-term survival in patients with acute leukemia and chronic disseminated candidiasis despite minimal antileukemic therapy","volume":"91","author":"Karthaus","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB327|cit327","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/blood.V84.8.2811.2811","article-title":"Hepatosplenic candidiasis - a contraindication to marrow transplantation?","volume":"84","author":"Bjerke","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB328|cit328","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/1097-0142(19951201)76:11<2357::AID-CNCR2820761126>3.0.CO;2-H","article-title":"Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia","volume":"76","author":"Walsh","year":"1995","journal-title":"Cancer"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB329|cit329","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/AAC.41.9.1944","article-title":"Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis","volume":"41","author":"Walsh","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB330|cit330","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9343(91)90006-J","article-title":"Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy","volume":"91","author":"Anaissie","year":"1991","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB331|cit331","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9343(91)90005-I","article-title":"Hepatosplenic candidiasis: successful treatment with fluconazole","volume":"91","author":"Kauffman","year":"1991","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB332|cit332","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/527390","article-title":"Adjuvant corticosteroid therapy for chronic disseminated candidiasis","volume":"46","author":"Legrand","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB333|cit333","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3476(95)70321-7","article-title":"Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group","volume":"127","author":"Flynn","year":"1995","journal-title":"J Pediatr"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB334|cit334","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)00307-0","article-title":"Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV\/AIDS patients","volume":"104","author":"Graybill","year":"1998","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB335|cit335","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516342","article-title":"A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS","volume":"26","author":"Phillips","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB336|cit336","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1053\/gast.1996.v111.pm8898629","article-title":"Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis","volume":"111","author":"Barbaro","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB337|cit337","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1378\/chest.110.6.1507","article-title":"Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group","volume":"110","author":"Barbaro","year":"1996","journal-title":"Chest"},{"issue":"Suppl. 1","key":"10.1111\/j.1439-0507.2011.02040.x-BIB338|cit338","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1439-0507.1996.tb00514.x","article-title":"Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis","volume":"39","author":"Eichel","year":"1996","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB339|cit339","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1089\/088922299309919","article-title":"Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients","volume":"15","author":"Saag","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB340|cit340","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/jac\/33.5.1071","article-title":"Itraconazole cyclodextrin solution - effective treatment for HIV-related candidosis unresponsive to other azole therapy","volume":"33","author":"Cartledge","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB341|cit341","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00002030-199702000-00005","article-title":"Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidosis","volume":"11","author":"Cartledge","year":"1997","journal-title":"AIDS"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB342|cit342","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/322653","article-title":"A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients","volume":"33","author":"Ally","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB343|cit343","first-page":"2227","article-title":"Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS","volume":"12","author":"Hegener","year":"1998","journal-title":"AIDS"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB344|cit344","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/501457","article-title":"A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV\/AIDS","volume":"42","author":"Vazquez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB345|cit345","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/511039","article-title":"Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection","volume":"44","author":"Skiest","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB346|cit346","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/QAI.0b013e31817af47a","article-title":"A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis","volume":"48","author":"Vazquez","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB347|cit347","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.46.2.451-457.2002","article-title":"Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases","volume":"46","author":"Arathoon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB348|cit348","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00002030-199405000-00023","article-title":"Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients","volume":"8","author":"Vuffray","year":"1994","journal-title":"AIDS"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB349|cit349","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0002-9343(96)00303-8","article-title":"Etiology of esophageal disease in human immunodeficiency virus-infected patients who fail antifungal therapy","volume":"101","author":"Wilcox","year":"1996","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB350|cit350","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1086\/514028","article-title":"A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis","volume":"176","author":"Wilcox","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB351|cit351","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1053\/gast.1996.v110.pm8964406","article-title":"Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms","volume":"110","author":"Wilcox","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB352|cit352","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000239459","article-title":"Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients","volume":"42","author":"Lake","year":"1996","journal-title":"Chemotherapy"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB353|cit353","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/423378","article-title":"A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis","volume":"39","author":"Krause","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB354|cit354","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/088922202760265579","article-title":"Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofungin","volume":"18","author":"DiNubile","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB355|cit355","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00126334-200210010-00009","article-title":"Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole","volume":"31","author":"Kartsonis","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl. 1","key":"10.1111\/j.1439-0507.2011.02040.x-BIB356|cit356","first-page":"83","article-title":"Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine","volume":"34","author":"Brockmeyer","year":"1991","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB357|cit357","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1086\/323401","article-title":"A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis","volume":"33","author":"Villanueva","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB358|cit358","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01191-9","article-title":"A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis","volume":"113","author":"Villanueva","year":"2002","journal-title":"Am J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB359|cit359","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB360|cit360","first-page":"149","article-title":"Guideline for vulvovaginal candidiasis. 6 November 2002 status. Professional Society of Infections and Infection Immunology of the German Society of gynecology and obstetrics and German Language Mycologic Society e.V.","volume":"2","author":"Mendling","year":"2004","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB361|cit361","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1517\/14740338.2.5.475","article-title":"Antifungal drugs in pregnancy: a review","volume":"2","author":"Moudgal","year":"2003","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB362|cit362","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/13693780500096898","article-title":"Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis","volume":"43","author":"Wozniak","year":"2005","journal-title":"Med Mycol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB363|cit363","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bmj.328.7451.1306","article-title":"Vaginal discharge - causes, diagnosis, and treatment","volume":"328","author":"Mitchell","year":"2004","journal-title":"BMJ"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB364|cit364","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/313583","article-title":"Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group","volume":"30","author":"Kauffman","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB365|cit365","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/313580","article-title":"Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group","volume":"30","author":"Sobel","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB366|cit366","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1054-3589(08)60129-5","article-title":"Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development","volume":"44","author":"Groll","year":"1998","journal-title":"Adv Pharmacol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB367|cit367","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1086\/510432","article-title":"Caspofungin in the treatment of symptomatic candiduria","volume":"44","author":"Sobel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB368|cit368","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1155\/2007\/768734","article-title":"Treatment of candiduria with micafungin: a case series","volume":"18","author":"Lagrotteria","year":"2007","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB369|cit369","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1610-0387.2006.05888.x","article-title":"Candidiasis of the skin","volume":"4","author":"Seebacher","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB370|cit370","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00431-007-0527-7","article-title":"Fungal infections in primary immunodeficiencies","volume":"166","author":"Antachopoulos","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB371|cit371","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1056\/NEJMoa0901053","article-title":"Human dectin-1 deficiency and mucocutaneous fungal infections","volume":"361","author":"Ferwerda","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB372|cit372","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1086\/604714","article-title":"Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients","volume":"49","author":"Plantinga","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB373|cit373","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa0810719","article-title":"A homozygous CARD9 mutation in a family with susceptibility to fungal infections","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB374|cit374","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2340\/00015555-0165","article-title":"Successful treatment of azole-resistant chronic mucocutaneous candidosis with caspofungin","volume":"86","author":"Jayasinghe","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB375|cit375","doi-asserted-by":"crossref","first-page":"143","DOI":"10.11150\/kansenshogakuzasshi1970.79.143","article-title":"A case of chronic mucocutaneous candidasis cured with micafungin","volume":"79","author":"Suzuki","year":"2005","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB376|cit376","first-page":"1","article-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Third Informational Supplement","volume":"28","author":"Clinical and Laboratory Standards Institute","year":"2010","journal-title":"Clinical and Laboratory Standards Institute"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB377|cit377","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/516314","article-title":"Amphotericin B colloidal dispersion for treatment of candidemia in immunocompromised patients","volume":"26","author":"Noskin","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB378|cit378","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/infdis\/173.5.1208","article-title":"Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant","volume":"173","author":"Bowden","year":"1996","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1111\/j.1439-0507.2011.02040.x-BIB379|cit379","doi-asserted-by":"crossref","first-page":"P131","DOI":"10.1186\/cc2020","article-title":"Itraconazole IV solution in the treatment of candidemia in non-neutropenic patients","volume":"7","author":"Tuil","year":"2003","journal-title":"Crit Care"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB380|cit380","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1086\/507547","article-title":"Mycograb for the treatment of invasive candidiasis","volume":"43","author":"Herbrecht","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB381|cit381","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0732-8893(00)00140-1","article-title":"The central nervous system and infection by Candida species","volume":"37","author":"Sanchez-Portocarrero","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl. 2","key":"10.1111\/j.1439-0507.2011.02040.x-BIB382|cit382","first-page":"41","article-title":"Status of fluconazole in the therapy of endogenous Candida endophthalmitis","volume":"41","author":"Penk","year":"1998","journal-title":"Mycoses"},{"issue":"Suppl. 2","key":"10.1111\/j.1439-0507.2011.02040.x-BIB383|cit383","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1439-0507.1998.tb00601.x","article-title":"Fungal arthritis - a rare complication of systemic candidiasis or orthopedic intervention. Review of therapeutic experience with fluconazole","volume":"41","author":"Penk","year":"1998","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2011.02040.x-BIB384|cit384","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/clinids\/21.4.960","article-title":"Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria","volume":"21","author":"Fan-Havard","year":"1995","journal-title":"Clin Infect Dis"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2011.02040.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1439-0507.2011.02040.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T11:37:32Z","timestamp":1686137852000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2011.02040.x"}},"subtitle":["Diagnosis and therapy of Candida infections"],"short-title":[],"issued":{"date-parts":[[2011,6,15]]},"references-count":384,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2011.02040.x","relation":{},"ISSN":["0933-7407"],"issn-type":[{"value":"0933-7407","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,15]]}}}